2024. Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s375. DOI:https://doi.org/10.25251/skin.8.supp.375.